DIA Postpones Conference on Drug Discovery and Clinical Development in India
Due to the tragic events that have taken place in Mumbai, DIA has postponed its 3rd Annual Conference on Drug Discovery and Clinical Development in India (December 7-10, 2008).
DRUG INFORMATION ASSOCIATION (DIA) POSTPONES 3RD ANNUAL CONFERENCE ON DRUG DISCOVERY AND CLINICAL DEVELOPMENT IN INDIA
WHO:
Drug Information Association (DIA)
WHAT:
3rd Annual Conference on Drug Discovery and Clinical Development in India
WHERE:
Renaissance Mumbai Hotel and Convention Centre
Mumbai, India
WHEN:
December 7-10, 2008
WHY:
Due to the tragic events that have taken place in Mumbai, DIA has postponed its 3rd Annual Conference on Drug Discovery and Clinical Development in India (December 7-10, 2008). The DIA Board of Directors, operational staff, and members and volunteers express their sympathies to the many people affected by the past week’s events. DIA is currently making plans to present this conference in February 2009 and will contact you with updated information about specific dates as soon as this information becomes available.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
